Last reviewed · How we verify
NCT04158986: NurseAID
Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis
NA trial testing Nurse-driven post-discharge intervention in Liver Cirrhosis in 110 participants. Completed in 1 October 2022.
13 October 2021
Quick facts
| Lead sponsor | Copenhagen University Hospital, Hvidovre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 110 |
| Start date | 1 December 2019 |
| Primary completion | 13 October 2021 |
| Estimated completion | 1 October 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Nurse-driven post-discharge intervention
Conditions studied
- Liver Cirrhosis — all drugs for Liver Cirrhosis →
Sponsor
Copenhagen University Hospital, Hvidovre
Who can join
18 and older, any sex, with Liver Cirrhosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis compared with standard follow-up will be investigated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis.
Barfod O'Connell M, Brødsgaard A, Matthè M, Hobolth L, et al · · 2024 · cited 2× · PMID 38668732 · DOI 10.1097/hc9.0000000000000418
Verify or expand the search:
- PubMed search for NCT04158986
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Cirrhosis
Currently open trials in the same condition.
- NCT07439939 — Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Place · recruiting
- NCT07325526 — A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- · Phase 2 · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07201649 — Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcificati · NA · recruiting
- NCT07252102 — Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients · NA · recruiting
Other Copenhagen University Hospital, Hvidovre trials
Trials by the same sponsor.
- NCT07321379 — Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour · NA · not yet recruiting
- NCT07067060 — Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty · not yet recruiting
- NCT06967324 — GRACE - Graduated Response for Advanced COPD With Enhanced Support · NA · recruiting
- NCT06682260 — Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure · Phase 4 · completed
- NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04158986 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital, Hvidovre
- Last refreshed: 30 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04158986.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing